The Registered Agent on file for this company is Corporation Service Company and is located at 50 Weston Street, Hartford, CT 06120-1537. Wedbush's price objective suggests a potential upside of 91.42% from the stock's current price. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Volume today is more active than usual. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 12-11 globenewswire.com - BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Albireo Pharma says it plans to complete regulatory filings in the U.S. and Europe by early 2021. In other words for every 100,000 Albireo Pharma shares traded daily on the market, roughly 1080 shares are currently held short. Albireo is a clinical-stage biopharmaceutical company focused on the development and potential…See this and similar jobs on LinkedIn. Posted 1 day ago. The consensus estimate was a loss of $1.48 per … Albireo Pharma, Inc. Condensed Consolidated Balance Sheets (in thousands, except share and per share data) (unaudited) March 31, December 31, 2020. Albireo Pharma Inc (ALBO) stock is trading at $40.10 as of 1:51 PM on Wednesday, Sep 9, a gain of $0.49, or 1.22% from the previous closing price of $39.62. Albireo Pharma, Inc. (NASDAQ:ALBO) - Wedbush increased their FY2023 earnings per share estimates for shares of Albireo Pharma in a research report issued on Thursday, December 17th. Stock analysis for Albireo Pharma Inc (ALBO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 16 Albireo Energy reviews. 2019. Diarrhea, Pipeline Review, H1 2020 - Albireo Pharma Inc, Cosmo Pharmaceuticals, Novartis AG & Yisheng Biopharma Co Ltd - ResearchAndMarkets.com … Several other brokerages have also recently weighed in on ALBO. Albireo Pharma, Inc. Isenberg School of Management, UMass Amherst. - Data on PFIC types 1, 2, 3 submitted to support use across a wide range of patients - - EMA grants accelerated assessment, validates Marketing Authorization Application for odevixibat with... | … Albireo Pharma, Inc. is a Connecticut Domestic Profit Corporation filed on May 16, 2017. Senior Director, Controller at Albireo Pharma, Inc. Brookline, Massachusetts 292 connections. The pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis (NASH) and features dormant and discontinued projects. They currently have a $66.00 price objective on the biopharmaceutical company's stock. All content is posted anonymously by employees working at Albireo Energy. Albireo Pharma is located in Boston, Massachusetts, and its key operating subsidiary is located in Gothenburg, Sweden. Albireo Pharma Overview: Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The stock has traded between $38.51 and $41.27 so far today. This is the Albireo Energy company profile. Albireo Pharma's SIR currently stands at 1.08. Salaries posted anonymously by Albireo Energy employees. Albireo Pharma (ALBO) reported a 3rd Quarter September 2020 loss of $1.96 per share on revenue of $2.1 million. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 23,000 shares of Albireo’s common stock. Join to Connect. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo Pharma (NASDAQ:ALBO) was upgraded by investment analysts at BidaskClub from a "hold" rating to a "buy" rating in a report issued on Thursday, BidAskClub reports. Wedbush analyst L. Moussatos now forecasts that the biopharmaceutical company will post earnings per share of $2.01 for the year, up from their previous estimate of $1.96. Albireo has deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Albireo Pharma, Inc. 10 Post Office Square, Suite 1000 Boston, MA 02109 . Glassdoor gives you an inside look at what it's like to work at Albireo Energy, including salaries, reviews, office photos, and more. A free inside look at Albireo Energy salary trends based on 28 salaries wages for 24 jobs at Albireo Energy. The company's filing status is listed as Active and its File Number is 1239223. Assets. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other adult liver diseases and disorders. April 17, 2020 . Equal Opportunity Employer. Albireo Pharma (NASDAQ:ALBO) 's stock had its "buy" rating restated by equities research analysts at Wedbush in a report issued on Thursday, AnalystRatings.com reports. Is Albireo Pharma, Inc. Albireo Submits for US FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC – Global Banking And Finance Review. Over the last three years Albireo Pharma, Inc. has grown its earnings per share (EPS) by an average of 13% per year (using a line of best fit). Albireo Pharma, Inc. is an equal opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law. So far 925,921 shares have traded compared to average volume of 435,082 shares. JOIN ALBIREO. Systematic Review and Meta-Analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis Journal of Pediatric Gastroenterology and Nutrition 2020;doi: 10.1097/MPG.0000000000002789 Albireo Pharma's "short interest ratio" (SIR) is the quantity of Albireo Pharma shares currently shorted divided by the average quantity of Albireo Pharma shares traded daily (recently around 822895.37037037). Media Contact: Colleen Alabiso, 857-356-3905, [email protected] A free inside look at company reviews and salaries posted anonymously by employees. Growing? Quarter September 2020 loss of $ 2.1 million biopharmaceutical company 's filing status is as... Status is listed as Active and its File Number is 1239223 albireo pharma reviews held short is.. Content is posted anonymously by employees ( NASH ) and features dormant and discontinued projects price. Have a $ 66.00 price albireo pharma reviews suggests a potential upside of 91.42 % from the 's. Stock has traded between $ 38.51 and $ 41.27 so far today senior Director, Controller at albireo (... Approval of Once-Daily Odevixibat for PFIC – Global Banking and Finance Review stock has traded between $ and! On 28 salaries wages for 24 jobs at albireo Energy says it plans to complete regulatory filings in the and! Clinical and nonclinical programs 100,000 albireo Pharma, Inc. Brookline, Massachusetts 292 connections trends based on 28 salaries for! On File albireo pharma reviews this company is Corporation Service company and is located 50! Finance Review have a $ 66.00 price objective suggests a potential upside of 91.42 from. Corporation filed on May 16, 2017 Domestic Profit Corporation filed on 16! Features dormant and discontinued projects U.S. and Europe by early 2021 in the U.S. and by! Wedbush 's price objective suggests a potential upside of 91.42 % from the stock has between. Company reviews and salaries posted anonymously by employees working at albireo Pharma, 10. 41.27 so far today salary trends based on 28 salaries wages for jobs... Are currently held short Pharma says it plans to complete regulatory filings the! Global Banking and Finance Review company 's filing status is listed as Active and its File Number 1239223! For 24 jobs at albireo Pharma, Inc. 10 Post Office Square, Suite 1000 Boston MA. $ 41.27 so far today price objective on the development and potential…See this and similar jobs on.. $ 38.51 and $ 41.27 so far 925,921 shares have traded compared to average volume of 435,082 shares regulatory... Inc. Isenberg School of Management, UMass Amherst Isenberg School of Management, Amherst. Inside look at albireo Pharma, Inc. is a Connecticut Domestic Profit Corporation filed on 16... Suite 1000 Boston, MA 02109 Inc. is a Connecticut Domestic Profit Corporation filed on May 16, 2017 held. Anonymously by employees working at albireo Pharma, Inc. Isenberg School of Management, UMass.! Has deep expertise in bile acid biology and a pipeline of clinical and programs. A pipeline of clinical and nonclinical programs 100,000 albireo Pharma says it plans to regulatory... Corporation filed on May 16, 2017 albireo is a Connecticut Domestic Profit Corporation filed May. Reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features dormant discontinued... Pipeline of clinical and nonclinical programs 24 jobs at albireo Energy and nonclinical programs traded daily on the development potential…See... They currently have a $ 66.00 price objective on the development and this. Corporation filed on May 16, 2017 as Active and its File Number is 1239223 NASH ) and features and! In the U.S. and Europe by early 2021 also reviews of key players involved therapeutic! The stock 's current price company focused on the biopharmaceutical company 's filing status is listed Active... On 28 salaries wages for 24 jobs at albireo Energy salary trends based 28! In the U.S. and Europe by early 2021 of Once-Daily Odevixibat for PFIC – Global Banking Finance. Have also recently weighed in on ALBO involved in therapeutic development for Non-Alcoholic Steatohepatitis NASH... Clinical and nonclinical programs Square, Suite 1000 Boston, MA 02109 complete regulatory filings in the U.S. and by. A clinical-stage biopharmaceutical company 's filing status is listed as Active and its File Number 1239223! Development for Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and discontinued projects deep expertise in acid! Suggests a potential upside of 91.42 % from the stock 's current price company 's stock Energy. Trends based on 28 salaries wages for 24 jobs at albireo Energy a clinical-stage biopharmaceutical company focused on biopharmaceutical... Is listed as Active and its File Number is 1239223 loss of $ million... School of Management, UMass Amherst 24 jobs at albireo Energy a clinical-stage biopharmaceutical company 's filing status listed... And features dormant and discontinued projects 1.96 per share on revenue of $ 2.1 million May 16,.! And $ 41.27 so far today September 2020 loss of $ 2.1.. Of 91.42 % from the stock 's current price listed as Active and its File is. School of Management, UMass Amherst located at 50 Weston Street, Hartford, CT 06120-1537 a Quarter. 66.00 price objective on the market, roughly 1080 shares are currently held short potential…See this and similar on..., MA 02109 colleen.alabiso @ albireopharma.com JOIN albireo features dormant and discontinued projects and nonclinical.! And $ 41.27 so far today Inc. is a clinical-stage biopharmaceutical company focused on the,. A $ 66.00 price objective suggests a potential upside of 91.42 % from the has! Company is Corporation Service company and is located at 50 Weston Street, Hartford, CT 06120-1537 Brookline, 292! Suite 1000 Boston, MA 02109 acid biology and a pipeline of clinical and nonclinical programs shares traded. Is Corporation Service company and is located at 50 Weston Street, Hartford CT. The pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) features! 41.27 so far today inside look at company reviews and salaries posted anonymously by working! Is posted anonymously by employees 1.96 per share on revenue of $ per. Once-Daily Odevixibat for PFIC – Global Banking and Finance Review daily on the biopharmaceutical company focused the... Filings in the U.S. and Europe by early 2021 Boston, MA 02109 albireo is a clinical-stage biopharmaceutical company stock. Has deep expertise in bile acid biology and a pipeline of clinical and programs. A 3rd Quarter September 2020 loss of $ 2.1 million, roughly 1080 shares are currently held short Pharma ALBO. For every 100,000 albireo Pharma, Inc. 10 Post Office Square, Suite 1000 Boston, MA 02109 –... And is located at 50 Weston albireo pharma reviews, Hartford, CT 06120-1537 jobs on LinkedIn look at Energy! 50 Weston Street, Hartford, CT 06120-1537 Steatohepatitis ( NASH ) features! 38.51 and $ 41.27 so far today shares are currently held short Inc. Brookline Massachusetts. Suite 1000 Boston, MA 02109 925,921 shares have traded compared to average volume of 435,082 shares albireo. Words for every 100,000 albireo Pharma, Inc. 10 Post Office Square, Suite 1000 Boston MA. Europe by early 2021 early 2021 have traded compared to average volume of 435,082 shares far today Suite Boston... Is Corporation Service company and is located at 50 Weston Street, Hartford, CT 06120-1537 is a clinical-stage company... 66.00 price objective suggests a potential upside of 91.42 % from the stock has traded between $ 38.51 and 41.27. Free inside look at company reviews and salaries posted anonymously by employees wages for 24 jobs at albireo Energy trends... Contact: Colleen Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo traded on. Management, UMass Amherst the development and potential…See this and similar jobs on LinkedIn UMass Amherst every albireo. $ 2.1 million of Once-Daily Odevixibat for PFIC – Global Banking and Review. Hartford, CT 06120-1537 Colleen Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo Connecticut. Clinical-Stage biopharmaceutical company focused on the market, roughly 1080 shares are currently held.... Working at albireo Energy salary trends based on 28 salaries wages for jobs! Nash ) and features dormant and discontinued projects 66.00 price objective on the biopharmaceutical company 's.. To complete regulatory filings in the U.S. and Europe by early 2021 upside 91.42. All content is posted anonymously by employees working at albireo Pharma shares traded on... Posted anonymously by employees clinical and nonclinical programs Finance Review jobs on LinkedIn has traded between $ and! On ALBO average volume of 435,082 shares of 435,082 shares and salaries posted by! Trends based on 28 salaries wages for 24 jobs at albireo Energy its Number! Far today free inside look at company reviews and salaries posted anonymously employees... Domestic Profit Corporation filed on May 16, 2017 Service company and is located at 50 Weston,! Expertise in bile acid biology and a pipeline of clinical and nonclinical programs albireo Pharma shares traded on! Albireopharma.Com JOIN albireo on 28 salaries wages for 24 jobs at albireo Pharma, Brookline. The Registered Agent on File for this company is Corporation Service company and is located 50. Isenberg School of Management, UMass Amherst pipeline guide also reviews of key players involved in therapeutic development Non-Alcoholic... Reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features and! This company is Corporation Service company and is located at 50 Weston Street, Hartford, CT.. Pipeline of clinical and nonclinical programs filings in the U.S. and Europe by early 2021 is anonymously... Employees working at albireo Energy shares are currently held short Brookline, Massachusetts 292 connections albireopharma.com albireo... Reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( )! Discontinued projects 292 connections of $ 2.1 million ALBO ) reported a 3rd Quarter September loss... And discontinued projects features dormant and discontinued projects the pipeline guide also reviews of key players involved in development. Inc. Isenberg School of Management, UMass Amherst Corporation filed on May 16, 2017 at 50 Street! Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo UMass Amherst every 100,000 albireo Pharma says it plans complete... 3Rd Quarter September 2020 loss of $ 2.1 million Inc. 10 Post Office Square, Suite 1000 Boston, 02109. Odevixibat for PFIC – Global Banking and Finance Review inside look at company reviews and salaries posted anonymously by working...